MindMate: A Study of a Reminder System for People With Dementia
NCT ID: NCT02908997
Last Updated: 2018-11-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
3 participants
INTERVENTIONAL
2017-01-17
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment With Namenda in Women at Risk for Cognitive Decline
NCT00242632
Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type
NCT03721705
Memantine for Agitation in Dementia
NCT00371059
Metformin in Alzheimer's Dementia Prevention
NCT04098666
MIND Diet Intervention and Cognitive Decline
NCT02817074
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Memory difficulties are a core feature of dementia. These include difficulties remembering to do something at a specific time and place in the future (Prospective Memory). Although a range of electronic prospective memory aids currently exist (e.g. "Neuropage"), the evidence supporting their use among the dementia population remains limited. "Mindmate" is a recently developed mobile application that aims to support individuals with a diagnosis of dementia, improving self-management skills and quality of life.
Aims
This study will explore the effectiveness of "MindMate" reminder alerts delivered to a smart phone or tablet computer as a memory aid for people with a diagnosis of Mild Dementia.
Method
Three participants with a diagnosis of dementia, who are considered to be in the early stages and who report everyday prospective memory difficulties, will be recruited from Older People Community Mental Health teams within Greater Glasgow and Clyde. The participants will own a smart phone or tablet and will be living with a partner or family member who will also participate in the study. During the initial baseline phase, the partner or family member will monitor the number of pre defined tasks the participant remembered and forgot. The partner or family member will record this information on a weekly monitoring form and this phase will last between five to seven weeks. This will be followed by a five-week intervention phase where "MindMate" reminder alerts will be sent to the participant's phone or tablet. Again, tasks that require remembering will be identified prior to the intervention phase, and family members or carers will monitor their success on a form. Results will be analysed using visual inspection and Tau-U analysis.
Applications
This study will provide information on the effectiveness of a form of assistive technology at supporting people with a dementia, which could improve quality of life of those with a diagnosis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
5 week baseline
5 week baseline data collection followed by 6 week MindMate intervention
MindMate
A dementia-specific mobile reminding application
6 week baseline
6 week baseline data collection followed by 6 week MindMate intervention
MindMate
A dementia-specific mobile reminding application
7 week baseline
7 week baseline data collection followed by 6 week MindMate intervention
MindMate
A dementia-specific mobile reminding application
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MindMate
A dementia-specific mobile reminding application
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* has received the diagnosis from a psychiatrist
* owns a smart phone or tablet
* has a family member/partner/carer who is willing to monitor memory aid use
* has capacity to consent to being involved in the research
* is reporting memory difficulties that are affecting them in daily life
Exclusion Criteria
* has a pre-existing neurological or severe psychiatric problem (e.g. bipolar disorder, psychosis)
* has a diagnosis of dementia that is considered to be in the moderate to severe stages
* those whose first language is not English
* those with a diagnosed or suspected developmental learning disability
* those who are currently using online or electronic memory aids
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Glasgow
OTHER
NHS Greater Glasgow and Clyde
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan Evans, BSc DClinPsy PhD
Role: PRINCIPAL_INVESTIGATOR
University of Glasgow
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NHS Greater Glasgow and Clyde
Glasgow, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GN16NE538
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.